Evidence map›Paper›PMID 31714431›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2019

Exosomal MicroRNAs Associate With Neuropsychological Performance in Individuals With HIV Infection on Antiretroviral Therapy.

Tess OʼMeara, Yong Kong, Jennifer Chiarella, Richard W Price, Rabib Chaudhury, Xinran Liu, Serena Spudich, Kevin Robertson, Brinda Emu, Lingeng Lu

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Tess OʼMearaYale School of Medicine, New Haven, CT.
Yong KongYale School of Public Health, New Haven, CT.
Jennifer ChiarellaYale School of Medicine, New Haven, CT.
Richard W PriceUniversity of California San Francisco School of Medicine, San Francisco, CA.
Rabib ChaudhuryYale School of Engineering and Applied Sciences, New Haven, CT.
Xinran LiuYale School of Medicine, New Haven, CT.
Serena SpudichYale School of Medicine, New Haven, CT.
Kevin RobertsonUniversity of North Carolina School of Medicine, Chapel Hill, NC.
Brinda EmuYale School of Medicine, New Haven, CT.
Lingeng LuYale School of Public Health, New Haven, CT.
Yale University · USUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
The Neuropathobiology of Primary HIV-1 InfectionR01MH081772 · NIMH · YALE UNIVERSITY · PI SPUDICH, SERENA S · 2008 to 2013
$2.7M
Central Nervous System Events in Primary HIV InfectionK23MH074466 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SPUDICH, SERENA S · 2005 to 2009
$835k
CSF & Blood Exosomal microRNAs, Immune Responses, and HAND in ART Suppressed HIVR21MH110260 · NIMH · YALE UNIVERSITY · PI EMU, BRINDA, SPUDICH, SERENA S · 2016 to 2017
$458k
NCATS NIH HHS UL1 TR001863NIMH NIH HHS K23 MH074466NIMH NIH HHS R01 MH081772NIMH NIH HHS R21 MH110260
6 · The paper itself

Abstract

backgroundNeurocognitive dysfunction remains prevalent among people living with HIV (PLWH), even after viral suppression on combination antiretroviral therapy (cART). We investigated associations between neuropsychological performance (NP) and patterns of circulating exosomal microRNA (exo-miRNA) expression in PLWH on cART.

settingA cross-sectional examination of plasma exo-miRNA among PLWH on cART with systemic viral suppression and volunteers without HIV infection.

methodsThirty-one PLWH who started cART during early infection (n = 19) or chronic infection (n = 12) participated in phlebotomy and an 11-test neuropsychological battery after >1 year on treatment. NP higher- or lower-performing participants were categorized based on normalized neuropsychological scores. Total RNA was extracted from purified exosomes of 31 PLWH and 5 volunteers without HIV and subject to small RNA sequencing. Differential expression of exo-miRNAs was examined and biological functions were predicted.

resultsEleven exo-miRNAs were up-regulated in NP lower-performing (n = 18) relative to higher-performing PLWH (n = 13). A high proportion of the differentiating exo-miRNA target the axon guidance KEGG pathway and neurotrophin tyrosine receptor kinase signaling Gene Ontology pathway. Differential expression analysis of exo-miRNAs between NP lower- (n = 7) and higher-performing (n = 12) PLWH within the early infection group alone confirmed largely consistent findings.

conclusionsPlasma exo-miRNA content differed between NP higher- and lower-performing PLWH. Several differentially expressed exo-miRNAs were predicted to be involved in inflammation and neurodegeneration pathways. Exo-miRNA in plasma may indicate cross-talk between the circulation and central nervous system and thus may be clinically relevant for neurocognitive dysfunction in PLWH.

Indexed as

AdultAnti-HIV AgentsCross-Sectional StudiesDrug Therapy, CombinationExosomesFemaleHIV InfectionsHumansMaleMicroRNAsMiddle AgedNeurocognitive DisordersNeuropsychological TestsSignal TransductionAnti-HIV AgentsMicroRNAs

Identifiers

PMID31714431
PMCPMC6857839
OpenAlexW2988825651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.